Daily Current Affairs Quiz Prelims Practice 2027
- The Exclusive Economic Zone (EEZ) extends up to 200 nautical miles from the coast.
- Territorial waters extend 12 nautical miles from the shore.
- Mechanised trawling is legally permitted throughout the 5 nautical mile inshore zone reserved for small-scale fishers.
- Mechanised boat fishing is closed for two months every year for stock rejuvenation.
- AOnly one
- BOnly two
- COnly three
- DAll four
Statements 1, 2 and 4 are accurate: the EEZ runs to 200 nautical miles, territorial waters extend to 12 nautical miles, and mechanised boat fishing is closed for two months annually for stock rejuvenation. Statement 3 is incorrect since the 5 nautical mile inshore zone is legally reserved for small-scale fishers, with mechanised trawling prohibited there, an attribute-reversal trap that turns a prohibition into a permission.
- AIt has been developed solely by the Defence Research and Development Organisation, without any private-sector partner.
- BIt is a 25-tonne, air-transportable light tank jointly developed by DRDO and L&T Defence for high-altitude operations along the LAC.
- CIt is intended to replace the T-90S Bhishma as India's main battle tank in the plains and desert sectors.
- DIt has been modelled on China's Type-15 light tank design for the LAC.
The Zorawar is a 25-tonne, air-transportable light tank jointly developed by DRDO and L&T Defence, purpose-built for high-altitude terrain along the LAC. Option (a) commits a role-omission trap by dropping L&T Defence's joint role, while option (c) is a category-conflation trap since Zorawar is a light mountain-warfare tank rather than a replacement for the T-90S Bhishma's main-battle-tank role in the plains and desert theatre. Option (d) reverses the relationship, as Zorawar was designed to counter China's Type-15, not modelled after it.
- A bypoll must ordinarily be held within six months of a seat falling vacant, under the RPA, 1951.
- If the remaining term of a seat is less than one year, the six-month bypoll mandate does not apply.
- The Election Commission, acting alone and without consulting the Union government, may certify that holding a bypoll within six months is difficult.
- Courts have generally deferred to the Election Commission's discretion in scheduling bypolls.
- A1, 2 and 4 only
- B1, 3 and 4 only
- C2, 3 and 4 only
- D1, 2, 3 and 4
Statements 1, 2 and 4 correctly reflect the position: the RPA, 1951 six-month rule, the less-than-one-year exception, and judicial deference to EC discretion in scheduling bypolls. Statement 3 fails an actor-conflation trap, since the certification of difficulty must be made by the Election Commission in consultation with the Union government, not by the EC unilaterally, a subtle but important agency mix-up common in constitutional-body questions.
- List-I: A. M. p. pentadactyla (nominate) B. M. p. pusilla C. M. p. aurita
- List-II: 1. Hainan Island 2. Central Nepal 3. Taiwan
- AA-1, B-2, C-3
- BA-3, B-1, C-2
- CA-2, B-3, C-1
- DA-3, B-2, C-1
The nominate subspecies M. p. pentadactyla is from Taiwan, M. p. pusilla from Hainan Island, and M. p. aurita, now revalidated as the distinct species Manis aurita or the Himalayan pangolin, from central Nepal. The distractor codes swap the locality pairings, an attribute-swap trap that is a classic taxonomy-matching pitfall where the names are familiar but the geography is scrambled.
- The NLEM currently lists more medicines than the WHO Model List of Essential Medicines.
- The NPPA enforces price ceilings on NLEM-listed drugs under the DPCO, 2013.
- The NLEM was last revised in 2022, while the WHO Model List has been revised twice since.
- All monoclonal antibodies used in cancer treatment are included in the NLEM.
- A2 and 3 only
- B1, 2 and 3
- C2, 3 and 4
- D1, 3 and 4
Statement 1 is a numerical-inversion trap, since the NLEM has 384 medicines against the WHO list's 523, meaning fewer rather than more. Statement 4 is an absolute-claim trap, as none of the nine monoclonal antibodies on the WHO list feature on the NLEM. Statements 2 and 3 are accurate, with the NPPA enforcing price ceilings on NLEM-listed drugs under the DPCO, 2013, and the NLEM last revised in 2022 while the WHO Model List has since been revised twice.


